Saul E. Rivkin

7.6k citations
127 papers · 5.8k indexed · 1 hit paper · h-index 40

Impact in

  • Oncology top 0.5%
    • Cancer Treatment and Pharmacology
    • Pancreatic and Hepatic Oncology Research
    • Lung Cancer Research Studies
    • Colorectal Cancer Treatments and Studies
    • Breast Cancer Treatment Studies

Papers in

    • Cancer Treatment and Pharmacology 27
    • Lung Cancer Research Studies 12
    • Pancreatic and Hepatic Oncology Research 11
    • Colorectal Cancer Treatments and Studies 10
    • Ovarian cancer diagnosis and treatment 22

Saul E. Rivkin

125 papers receiving 5.5k citations

Hit Papers

Phase III Study Comparing Gemcitabine Plus Cetuximab Versus Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma: Southwest Oncology Group–Directed Intergroup Trial S0205 2010 · 500 citations
5002010202620152020100200300400500

Peers

Saul E. Rivkin
Comparison fields: 5 of 110
  • Oncology 3.6k
  • Cancer Research 1.1k
  • Pulmonary and Respiratory Medicine 2.0k
  • Pathology and Forensic Medicine 815
  • Reproductive Medicine 352
Replace A.T. van Oosterom with:
A.T. van Oosterom Netherlands
Otilia Dalesio Netherlands
D. Spooner United Kingdom
Philippe A. Cassier France
A. Harstrick Germany
Dimosthenis Skarlos Greece
Federica Perrone Italy
R. Lamerz Germany
Lina Asmar United States
Gerasimos Aravantinos Greece
Saul E. Rivkin relative to A.T. van Oosterom Netherlands A.T. van Oosterom's profile →
Citations per field
00.5×1.5×
A.T. van Oosterom · 1×
Citations per year

Countries citing papers authored by Saul E. Rivkin

Since Specialization
Citations

This map shows the geographic impact of Saul E. Rivkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saul E. Rivkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saul E. Rivkin more than expected).

Fields of papers citing papers by Saul E. Rivkin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Saul E. Rivkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saul E. Rivkin. The network helps show where Saul E. Rivkin may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Saul E. Rivkin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Saul E. Rivkin Line = papers co-authored together Saul E. Rivkin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 201925
2 20083
3 200873
4 200611
5 200655
6 200554
7 200313
8 20035
9 20029
10 20005
11 199726
12 199482
13 19934
14 199316
15 1992272
16
Adjuvant combination chemotherapy cmfvp vs oophorectomy followed by cmfvp ocmfvp for premenopausal women with er positive operable breast cancer with positive axillary lymph nodes an intergroup study
19917
17 199172
18 199037
19
Combination chemotherapy for alkylator-resistant ovarian carcinoma: a preliminary report of a Southwest Oncology Group trial.
197913
20
Role of DTIC (NSC-45388) in the chemotherapy of sarcomas.
1976114

About Saul E. Rivkin

Saul E. Rivkin is a scholar working on Oncology, Reproductive Medicine, Cancer Research, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 127 papers that have together received 5.8k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (27 papers), Breast Cancer Treatment Studies (23 papers), Ovarian cancer diagnosis and treatment (22 papers), Lung Cancer Treatments and Mutations (13 papers), Neuroendocrine Tumor Research Advances (12 papers), Lung Cancer Research Studies (12 papers), Pancreatic and Hepatic Oncology Research (11 papers) and Colorectal Cancer Treatments and Studies (10 papers). The work is most often cited by research in Oncology (3.6k citations), Cancer Research (1.1k citations), Pulmonary and Respiratory Medicine (2.0k citations), Pathology and Forensic Medicine (815 citations) and Reproductive Medicine (352 citations). Saul E. Rivkin has collaborated with scholars based in United States, Egypt and Canada. Frequent co-authors include S P Balcerzak, Barth Hoogstraten, Robert M. OʼBryan, Laurence H. Baker, John Crowley, Geoffrey R. Weiss, Bart Barlogie, John J. Crowley, Thomas E. Moon and Peter M. Ravdin. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Investigational New Drugs, Blood and Journal of Neuro-Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026